Back

MCLA-128 PK-PD Analysis Paper

Translational PK-PD Modeling Analysis of MCLA-128, a HER2/HER3 Bispecific Monoclonal Antibody, to Predict Clinical Efficacious Exposure and Dose

Aurelia H. M. de Vries Schultink, Robert P. Doornbos, Alexander B. H. Bakker, Kees Bol, Mark Throsby, Cecile Geuijen, David Maussang, Jan H. M. Schellens, Jos H. Beijnen, and Alwin D. R. Huitema

Investigational New Drugs,  doi: 10.1007/s10637-018-0593-x.